Ultragenyx Pharmaceutical | Ventes

Sales Changement Date
Acadia Pharmaceuticals USD 205.8M 25.24M 2024-03
Agios Pharmaceuticals USD 8.19M 1.09M 2024-03
Alnylam Pharmaceuticals USD 494.33M 54.61M 2024-03
BioMarin Pharmaceutical USD 649M 2.79M 2024-03
Insmed USD 75.5M 8.19M 2024-03
Ionis Pharmaceuticals USD 119M 206M 2024-03
Kyowa Hakko Kirin JPY 105.57B 30.61B 2024-03
MacroGenics USD 10.72M 323K 2023-12
Moderna USD 167B 164.19B 2024-03
Neurocrine Biosciences USD 515.3M 100K 2024-03
PTC Therapeutics USD 210.12M 96.94M 2024-03
Regeneron Pharmaceuticals USD 3.15B 284.3M 2024-03
Sarepta Therapeutics USD 413.5M 16.72M 2024-03
Ultragenyx Pharmaceutical USD 108.8M 18.59M 2024-03
Vertex Pharmaceuticals USD 2.69B 172.3M 2024-03



Ultragenyx Pharmaceutical Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.